- Advertisement -spot_img
Friday, June 21, 2024

Top 10 CRO Solution Providers 2020

Given the complexity of drug and device development and the need to bring products to market rapidly, pharmaceutical companies are increasingly outsourcing their manufacturing and research. This kind of approach across the industry has led to a recent spike in the hiring of Contract research organizations CROs.

Businesses involved in CRO provide comprehensive services in drug discovery, development, and related legal issues for a wide variety of clients in the medical industry. In a nutshell, CROs specializes in specific areas of drug discovery and development for certain types of clients.

According to various market reports, the global contract research organization’s market value is in constant growth and is expected to exceed $51 billion by 2024. With the rising demand, the market is becoming competitive with large CROs going for mergers and acquisitions to increase the portfolio and reach. Meanwhile, small and medium-sized CROs are becoming more prominent with their sophisticated and personalized approach, contact flexibility, and budget-friendly services.

With expansions, consolidations, and innovations continuing throughout the CRO industry, the coming years are to be filled with challenges and new scopes for improvement in the pharmaceutical sectors and beyond. With this changing trend, drug developers have to look for partners who deliver reliable outcomes with comprehensive data and add support to their research. Therefore choosing the right CRO is a complex and crucial process. To bring down the complexities of choosing the right CRO, our editorial team and researchers have developed a list of ‘Top 10 CROs 2020’.  The below top ten CROs to watch are listed include both industry leaders who are steadily increasing their solutions and innovations while expanding their presence through strategic partnerships and innovative service offerings.

CMIC Group

Management:

Jenny Lin

Designation:

COO

Headquarters:

Japan

Website:

cmicgroup.com

CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward.

Charles River Laboratories

Management:

James C. Foster

Designation:

CEO

Headquarters:

Wilmington, MA

Website:

criver.com

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

Frontage Laboratories

Management:

Song Li

Designation:

CEO

Headquarters:

Exton, PA

Website:

frontagelab.com

We are a CRO providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. We have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients.

ICON plc

Management:

Steve Cutler

Designation:

CEO

Headquarters:

Ireland

Website:

iconplc.com

We are a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

IQVIA

Management:

Ari Bousbib

Designation:

CEO

Headquarters:

Durham, NC

Website:

iqvia.com

IQVIA is the Human Data Science Company™. We are inspired by the industry we serve and provide solutions that enable life sciences companies to innovate with confidence, maximize opportunities and ultimately drive human health outcomes forward.

Medpace

Management:

August Troendle

Designation:

President and CEO

Headquarters:

Cincinnati, OH

Website:

medpace.com

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.

NAMSA

Management:

John Gorski

Designation:

CEO & President

Headquarters:

Northwood, OH

Website:

namsa.com

Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO).

Parexel

Management:

Jamie Macdonald

Designation:

CEO

Headquarters:

Waltham, MA

Website:

parexel.com

Parexel is focused on the development of innovative new therapies to improve the world’s health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients.

PPD

Management:

David Simmons

Designation:

CEO & Chairman

Headquarters:

Wilmington, NC

Website:

ppd.com

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations.

Syneos Health

Management:

Alistair Macdonald

Designation:

CEO

Headquarters:

Raleigh, NC

Website:

syneoshealth.com

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities.

Translate »